FSA
Fort Sheridan Advisors’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.87M | Sell |
17,417
-7
| -0% | -$752 | 0.27% | 69 |
|
2025
Q1 | $1.76M | Sell |
17,424
-455
| -3% | -$45.9K | 0.27% | 68 |
|
2024
Q4 | $1.6M | Buy |
17,879
+240
| +1% | +$21.4K | 0.23% | 76 |
|
2024
Q3 | $1.48M | Buy |
17,639
+410
| +2% | +$34.4K | 0.22% | 76 |
|
2024
Q2 | $1.33M | Buy |
17,229
+3,786
| +28% | +$292K | 0.21% | 79 |
|
2024
Q1 | $921K | Buy |
13,443
+1,805
| +16% | +$124K | 0.17% | 87 |
|
2023
Q4 | $673K | Sell |
11,638
-3
| -0% | -$173 | 0.13% | 103 |
|
2023
Q3 | $615K | Buy |
11,641
+2,530
| +28% | +$134K | 0.14% | 104 |
|
2023
Q2 | $493K | Buy |
9,111
+724
| +9% | +$39.2K | 0.11% | 121 |
|
2023
Q1 | $420K | Buy |
8,387
+148
| +2% | +$7.4K | 0.11% | 126 |
|
2022
Q4 | $381K | Hold |
8,239
| – | – | 0.12% | 122 |
|
2022
Q3 | $319K | Hold |
8,239
| – | – | 0.11% | 129 |
|
2022
Q2 | $307K | Hold |
8,239
| – | – | 0.1% | 133 |
|
2022
Q1 | $365K | Hold |
8,239
| – | – | 0.11% | 125 |
|
2021
Q4 | $350K | Sell |
8,239
-4
| -0% | -$170 | 0.1% | 135 |
|
2021
Q3 | $358K | Buy |
+8,243
| New | +$358K | 0.12% | 128 |
|